Patients with stage IV non-small cell lung cancer (NSCLC) from 1995 to 2001 lived for five years after diagnosis and had only two percent survival, according to the reports from the National Cancer Institute. But, according to a recent study published in the iJournal of Thoracic Oncology/i, 50 percent of patients were alive 6.8 years later after diagnosis of stage IV NSCLC, whose tumors test positive for rearrangements of the gene ALK (ALK+ NSCLC). These patients treated at UCHealth University of Colorado Hospital between 2009 and 2017....
Patients with stage IV non-small cell lung cancer (NSCLC) from 1995 to 2001 lived for five years after diagnosis and had only two percent survival, according to the reports from the National Cancer Institute. But, according to a recent study published in the iJournal of Thoracic Oncology/i, 50 percent of patients were alive 6.8 years later after diagnosis of stage IV NSCLC, whose tumors test positive for rearrangements of the gene ALK (ALK+ NSCLC). These patients treated at UCHealth University of Colorado Hospital between 2009 and 2017....